nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—coronary artery disease—atherosclerosis	0.164	1	CtDrD
Lovastatin—Simvastatin—atherosclerosis	0.147	0.5	CrCtD
Lovastatin—Pravastatin—atherosclerosis	0.147	0.5	CrCtD
Lovastatin—PON3—atherosclerosis	0.111	0.781	CbGaD
Lovastatin—Simvastatin—Pravastatin—atherosclerosis	0.0872	0.5	CrCrCtD
Lovastatin—Pravastatin—Simvastatin—atherosclerosis	0.0872	0.5	CrCrCtD
Lovastatin—HMGCR—atherosclerosis	0.0311	0.219	CbGaD
Lovastatin—HMGCR—Rosuvastatin—atherosclerosis	0.0181	0.119	CbGbCtD
Lovastatin—HMGCR—Simvastatin—atherosclerosis	0.0168	0.111	CbGbCtD
Lovastatin—HMGCR—Pravastatin—atherosclerosis	0.0164	0.108	CbGbCtD
Lovastatin—UGT1A3—Ezetimibe—atherosclerosis	0.00867	0.0572	CbGbCtD
Lovastatin—UGT1A3—Simvastatin—atherosclerosis	0.00806	0.0532	CbGbCtD
Lovastatin—UGT2B7—Ezetimibe—atherosclerosis	0.00627	0.0414	CbGbCtD
Lovastatin—UGT2B7—Simvastatin—atherosclerosis	0.00583	0.0385	CbGbCtD
Lovastatin—UGT1A1—Ezetimibe—atherosclerosis	0.00542	0.0357	CbGbCtD
Lovastatin—UGT1A1—Simvastatin—atherosclerosis	0.00504	0.0332	CbGbCtD
Lovastatin—SLCO1A2—Rosuvastatin—atherosclerosis	0.00398	0.0262	CbGbCtD
Lovastatin—SLCO1B1—Ezetimibe—atherosclerosis	0.00375	0.0248	CbGbCtD
Lovastatin—SLCO1B1—Rosuvastatin—atherosclerosis	0.00375	0.0248	CbGbCtD
Lovastatin—SLCO1A2—Simvastatin—atherosclerosis	0.0037	0.0244	CbGbCtD
Lovastatin—SLCO1A2—Pravastatin—atherosclerosis	0.00362	0.0239	CbGbCtD
Lovastatin—SLCO1B1—Simvastatin—atherosclerosis	0.00349	0.023	CbGbCtD
Lovastatin—SLCO1B1—Pravastatin—atherosclerosis	0.00341	0.0225	CbGbCtD
Lovastatin—ABCC2—Ezetimibe—atherosclerosis	0.0033	0.0217	CbGbCtD
Lovastatin—ABCC2—Simvastatin—atherosclerosis	0.00307	0.0202	CbGbCtD
Lovastatin—ABCC2—Pravastatin—atherosclerosis	0.003	0.0198	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.00205	0.0135	CbGbCtD
Lovastatin—CYP3A7—Simvastatin—atherosclerosis	0.00205	0.0135	CbGbCtD
Lovastatin—CYP3A5—Rosuvastatin—atherosclerosis	0.00165	0.0109	CbGbCtD
Lovastatin—CYP3A5—Simvastatin—atherosclerosis	0.00154	0.0101	CbGbCtD
Lovastatin—CYP3A5—Pravastatin—atherosclerosis	0.0015	0.00991	CbGbCtD
Lovastatin—CYP2C8—Simvastatin—atherosclerosis	0.00148	0.00974	CbGbCtD
Lovastatin—CYP2C8—Pravastatin—atherosclerosis	0.00144	0.00953	CbGbCtD
Lovastatin—CYP2C19—Rosuvastatin—atherosclerosis	0.00133	0.00879	CbGbCtD
Lovastatin—CYP2C19—Simvastatin—atherosclerosis	0.00124	0.00817	CbGbCtD
Lovastatin—CYP2D6—Niacin—atherosclerosis	0.00119	0.00786	CbGbCtD
Lovastatin—CYP2C9—Rosuvastatin—atherosclerosis	0.00111	0.00731	CbGbCtD
Lovastatin—ABCB1—Ezetimibe—atherosclerosis	0.00107	0.00709	CbGbCtD
Lovastatin—CYP2C9—Simvastatin—atherosclerosis	0.00103	0.00679	CbGbCtD
Lovastatin—CYP2C9—Pravastatin—atherosclerosis	0.00101	0.00665	CbGbCtD
Lovastatin—ABCB1—Simvastatin—atherosclerosis	0.000999	0.00659	CbGbCtD
Lovastatin—ABCB1—Pravastatin—atherosclerosis	0.000978	0.00645	CbGbCtD
Lovastatin—CYP2D6—Simvastatin—atherosclerosis	0.000941	0.00621	CbGbCtD
Lovastatin—CYP2D6—Pravastatin—atherosclerosis	0.000921	0.00608	CbGbCtD
Lovastatin—ITGAL—endothelium—atherosclerosis	0.000725	0.15	CbGeAlD
Lovastatin—ITGAL—blood vessel—atherosclerosis	0.000668	0.138	CbGeAlD
Lovastatin—CYP3A4—Ezetimibe—atherosclerosis	0.000644	0.00425	CbGbCtD
Lovastatin—CYP3A4—Rosuvastatin—atherosclerosis	0.000644	0.00425	CbGbCtD
Lovastatin—CYP3A4—Simvastatin—atherosclerosis	0.000599	0.00395	CbGbCtD
Lovastatin—CYP3A4—Pravastatin—atherosclerosis	0.000586	0.00386	CbGbCtD
Lovastatin—Simvastatin—HMGCR—atherosclerosis	0.0004	0.505	CrCbGaD
Lovastatin—Pravastatin—HMGCR—atherosclerosis	0.000391	0.495	CrCbGaD
Lovastatin—ITGAL—connective tissue—atherosclerosis	0.000343	0.0709	CbGeAlD
Lovastatin—ITGAL—cardiovascular system—atherosclerosis	0.000298	0.0617	CbGeAlD
Lovastatin—HDAC2—Fluvastatin—Rosuvastatin—atherosclerosis	0.000275	0.511	CbGdCrCtD
Lovastatin—ITGAL—adipose tissue—atherosclerosis	0.000263	0.0544	CbGeAlD
Lovastatin—HDAC2—Simvastatin—Pravastatin—atherosclerosis	0.000263	0.489	CbGdCrCtD
Lovastatin—PON3—adipose tissue—atherosclerosis	0.000258	0.0534	CbGeAlD
Lovastatin—ITGAL—liver—atherosclerosis	0.000184	0.0382	CbGeAlD
Lovastatin—PON3—liver—atherosclerosis	0.000181	0.0374	CbGeAlD
Lovastatin—UGT1A3—liver—atherosclerosis	0.000157	0.0325	CbGeAlD
Lovastatin—HDAC2—connective tissue—atherosclerosis	0.000137	0.0284	CbGeAlD
Lovastatin—HMGCR—connective tissue—atherosclerosis	0.000124	0.0256	CbGeAlD
Lovastatin—HDAC2—cardiovascular system—atherosclerosis	0.000119	0.0247	CbGeAlD
Lovastatin—HMGCR—cardiovascular system—atherosclerosis	0.000108	0.0223	CbGeAlD
Lovastatin—HDAC2—adipose tissue—atherosclerosis	0.000105	0.0218	CbGeAlD
Lovastatin—HMGCR—adipose tissue—atherosclerosis	9.48e-05	0.0196	CbGeAlD
Lovastatin—CYP3A7—liver—atherosclerosis	9.29e-05	0.0192	CbGeAlD
Lovastatin—UGT2B7—liver—atherosclerosis	9e-05	0.0186	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—liver—atherosclerosis	7.9e-05	0.0164	CbGeAlD
Lovastatin—UGT1A1—liver—atherosclerosis	7.65e-05	0.0159	CbGeAlD
Lovastatin—HDAC2—liver—atherosclerosis	7.37e-05	0.0153	CbGeAlD
Lovastatin—HMGCR—liver—atherosclerosis	6.65e-05	0.0138	CbGeAlD
Lovastatin—SLCO1B1—liver—atherosclerosis	6.37e-05	0.0132	CbGeAlD
Lovastatin—ABCB1—blood vessel—atherosclerosis	6.29e-05	0.013	CbGeAlD
Lovastatin—Purpura—Simvastatin—atherosclerosis	5.91e-05	0.0013	CcSEcCtD
Lovastatin—Hepatic function abnormal—Pravastatin—atherosclerosis	5.89e-05	0.0013	CcSEcCtD
Lovastatin—Photosensitivity—Pravastatin—atherosclerosis	5.87e-05	0.00129	CcSEcCtD
Lovastatin—Arthritis—Simvastatin—atherosclerosis	5.86e-05	0.00129	CcSEcCtD
Lovastatin—Vascular purpura—Pravastatin—atherosclerosis	5.76e-05	0.00127	CcSEcCtD
Lovastatin—Hepatic failure—Pravastatin—atherosclerosis	5.73e-05	0.00126	CcSEcCtD
Lovastatin—Haemolytic anaemia—Pravastatin—atherosclerosis	5.71e-05	0.00126	CcSEcCtD
Lovastatin—Injury—Pravastatin—atherosclerosis	5.6e-05	0.00123	CcSEcCtD
Lovastatin—Amnesia—Pravastatin—atherosclerosis	5.48e-05	0.00121	CcSEcCtD
Lovastatin—Neuropathy peripheral—Rosuvastatin—atherosclerosis	5.43e-05	0.0012	CcSEcCtD
Lovastatin—Urinary tract infection—Rosuvastatin—atherosclerosis	5.38e-05	0.00119	CcSEcCtD
Lovastatin—Arthritis—Niacin—atherosclerosis	5.38e-05	0.00119	CcSEcCtD
Lovastatin—Cramp muscle—Ezetimibe—atherosclerosis	5.38e-05	0.00118	CcSEcCtD
Lovastatin—Purpura—Pravastatin—atherosclerosis	5.34e-05	0.00118	CcSEcCtD
Lovastatin—Arthritis—Pravastatin—atherosclerosis	5.3e-05	0.00117	CcSEcCtD
Lovastatin—CYP2C9—cardiovascular system—atherosclerosis	5.2e-05	0.0108	CbGeAlD
Lovastatin—Sinusitis—Rosuvastatin—atherosclerosis	5.2e-05	0.00114	CcSEcCtD
Lovastatin—SLCO1A2—liver—atherosclerosis	5.18e-05	0.0107	CbGeAlD
Lovastatin—Influenza—Ezetimibe—atherosclerosis	5.16e-05	0.00114	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	5.13e-05	0.00113	CcSEcCtD
Lovastatin—Cramp muscle—Simvastatin—atherosclerosis	5.13e-05	0.00113	CcSEcCtD
Lovastatin—Eosinophilia—Ezetimibe—atherosclerosis	5.11e-05	0.00113	CcSEcCtD
Lovastatin—Pancreatitis—Ezetimibe—atherosclerosis	5.06e-05	0.00112	CcSEcCtD
Lovastatin—Hepatitis—Rosuvastatin—atherosclerosis	4.97e-05	0.0011	CcSEcCtD
Lovastatin—Eosinophilia—Simvastatin—atherosclerosis	4.88e-05	0.00107	CcSEcCtD
Lovastatin—ABCC2—liver—atherosclerosis	4.83e-05	0.01	CbGeAlD
Lovastatin—Pancreatitis—Simvastatin—atherosclerosis	4.83e-05	0.00106	CcSEcCtD
Lovastatin—Erectile dysfunction—Ezetimibe—atherosclerosis	4.76e-05	0.00105	CcSEcCtD
Lovastatin—Abdominal discomfort—Simvastatin—atherosclerosis	4.72e-05	0.00104	CcSEcCtD
Lovastatin—Photosensitivity reaction—Ezetimibe—atherosclerosis	4.71e-05	0.00104	CcSEcCtD
Lovastatin—CYP3A5—adipose tissue—atherosclerosis	4.66e-05	0.00965	CbGeAlD
Lovastatin—Cramp muscle—Pravastatin—atherosclerosis	4.64e-05	0.00102	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	4.64e-05	0.00102	CcSEcCtD
Lovastatin—Erectile dysfunction—Simvastatin—atherosclerosis	4.54e-05	0.000999	CcSEcCtD
Lovastatin—Influenza—Niacin—atherosclerosis	4.52e-05	0.000996	CcSEcCtD
Lovastatin—Neuropathy peripheral—Ezetimibe—atherosclerosis	4.51e-05	0.000994	CcSEcCtD
Lovastatin—Photosensitivity reaction—Simvastatin—atherosclerosis	4.49e-05	0.00099	CcSEcCtD
Lovastatin—Influenza—Pravastatin—atherosclerosis	4.45e-05	0.000981	CcSEcCtD
Lovastatin—Eosinophilia—Pravastatin—atherosclerosis	4.41e-05	0.000971	CcSEcCtD
Lovastatin—Pancreatitis—Pravastatin—atherosclerosis	4.36e-05	0.000961	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	4.35e-05	0.000959	CcSEcCtD
Lovastatin—Sinusitis—Ezetimibe—atherosclerosis	4.32e-05	0.000951	CcSEcCtD
Lovastatin—Neuropathy peripheral—Simvastatin—atherosclerosis	4.3e-05	0.000948	CcSEcCtD
Lovastatin—Flatulence—Rosuvastatin—atherosclerosis	4.27e-05	0.000939	CcSEcCtD
Lovastatin—Erectile dysfunction—Niacin—atherosclerosis	4.16e-05	0.000917	CcSEcCtD
Lovastatin—CYP2C19—liver—atherosclerosis	4.15e-05	0.00859	CbGeAlD
Lovastatin—Hepatitis—Ezetimibe—atherosclerosis	4.13e-05	0.00091	CcSEcCtD
Lovastatin—Sinusitis—Simvastatin—atherosclerosis	4.12e-05	0.000907	CcSEcCtD
Lovastatin—Erectile dysfunction—Pravastatin—atherosclerosis	4.1e-05	0.000903	CcSEcCtD
Lovastatin—Photosensitivity reaction—Pravastatin—atherosclerosis	4.06e-05	0.000895	CcSEcCtD
Lovastatin—Angioedema—Rosuvastatin—atherosclerosis	3.95e-05	0.000871	CcSEcCtD
Lovastatin—Hepatitis—Simvastatin—atherosclerosis	3.94e-05	0.000868	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	3.94e-05	0.000867	CcSEcCtD
Lovastatin—Erythema multiforme—Ezetimibe—atherosclerosis	3.91e-05	0.000861	CcSEcCtD
Lovastatin—Neuropathy peripheral—Pravastatin—atherosclerosis	3.89e-05	0.000857	CcSEcCtD
Lovastatin—Urinary tract infection—Pravastatin—atherosclerosis	3.86e-05	0.00085	CcSEcCtD
Lovastatin—Flushing—Ezetimibe—atherosclerosis	3.84e-05	0.000845	CcSEcCtD
Lovastatin—Erythema multiforme—Simvastatin—atherosclerosis	3.73e-05	0.000821	CcSEcCtD
Lovastatin—Sinusitis—Pravastatin—atherosclerosis	3.72e-05	0.00082	CcSEcCtD
Lovastatin—Myalgia—Rosuvastatin—atherosclerosis	3.68e-05	0.000812	CcSEcCtD
Lovastatin—Arthralgia—Rosuvastatin—atherosclerosis	3.68e-05	0.000812	CcSEcCtD
Lovastatin—Flushing—Simvastatin—atherosclerosis	3.66e-05	0.000806	CcSEcCtD
Lovastatin—Alopecia—Ezetimibe—atherosclerosis	3.65e-05	0.000804	CcSEcCtD
Lovastatin—CYP2C8—liver—atherosclerosis	3.62e-05	0.0075	CbGeAlD
Lovastatin—Hepatitis—Niacin—atherosclerosis	3.62e-05	0.000797	CcSEcCtD
Lovastatin—Hepatitis—Pravastatin—atherosclerosis	3.56e-05	0.000785	CcSEcCtD
Lovastatin—Confusional state—Rosuvastatin—atherosclerosis	3.56e-05	0.000785	CcSEcCtD
Lovastatin—Flatulence—Ezetimibe—atherosclerosis	3.55e-05	0.000781	CcSEcCtD
Lovastatin—Chills—Simvastatin—atherosclerosis	3.54e-05	0.000779	CcSEcCtD
Lovastatin—Infection—Rosuvastatin—atherosclerosis	3.51e-05	0.000773	CcSEcCtD
Lovastatin—Alopecia—Simvastatin—atherosclerosis	3.48e-05	0.000767	CcSEcCtD
Lovastatin—Back pain—Ezetimibe—atherosclerosis	3.48e-05	0.000767	CcSEcCtD
Lovastatin—Muscle spasms—Ezetimibe—atherosclerosis	3.46e-05	0.000762	CcSEcCtD
Lovastatin—Thrombocytopenia—Rosuvastatin—atherosclerosis	3.46e-05	0.000762	CcSEcCtD
Lovastatin—Flatulence—Simvastatin—atherosclerosis	3.38e-05	0.000745	CcSEcCtD
Lovastatin—Erythema multiforme—Pravastatin—atherosclerosis	3.37e-05	0.000742	CcSEcCtD
Lovastatin—Dysgeusia—Simvastatin—atherosclerosis	3.36e-05	0.00074	CcSEcCtD
Lovastatin—Flushing—Niacin—atherosclerosis	3.36e-05	0.00074	CcSEcCtD
Lovastatin—Ill-defined disorder—Ezetimibe—atherosclerosis	3.34e-05	0.000735	CcSEcCtD
Lovastatin—Flushing—Pravastatin—atherosclerosis	3.31e-05	0.000728	CcSEcCtD
Lovastatin—Muscle spasms—Simvastatin—atherosclerosis	3.3e-05	0.000727	CcSEcCtD
Lovastatin—Angioedema—Ezetimibe—atherosclerosis	3.29e-05	0.000724	CcSEcCtD
Lovastatin—CYP3A5—liver—atherosclerosis	3.27e-05	0.00677	CbGeAlD
Lovastatin—Chills—Niacin—atherosclerosis	3.25e-05	0.000715	CcSEcCtD
Lovastatin—Malaise—Ezetimibe—atherosclerosis	3.24e-05	0.000715	CcSEcCtD
Lovastatin—Vision blurred—Simvastatin—atherosclerosis	3.23e-05	0.000712	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	3.22e-05	0.000709	CcSEcCtD
Lovastatin—CYP2C9—liver—atherosclerosis	3.22e-05	0.00666	CbGeAlD
Lovastatin—Tremor—Simvastatin—atherosclerosis	3.21e-05	0.000708	CcSEcCtD
Lovastatin—Alopecia—Niacin—atherosclerosis	3.2e-05	0.000704	CcSEcCtD
Lovastatin—Chills—Pravastatin—atherosclerosis	3.2e-05	0.000704	CcSEcCtD
Lovastatin—Insomnia—Rosuvastatin—atherosclerosis	3.19e-05	0.000704	CcSEcCtD
Lovastatin—Ill-defined disorder—Simvastatin—atherosclerosis	3.18e-05	0.000701	CcSEcCtD
Lovastatin—Paraesthesia—Rosuvastatin—atherosclerosis	3.17e-05	0.000699	CcSEcCtD
Lovastatin—Alopecia—Pravastatin—atherosclerosis	3.15e-05	0.000694	CcSEcCtD
Lovastatin—Angioedema—Simvastatin—atherosclerosis	3.13e-05	0.000691	CcSEcCtD
Lovastatin—Dyspepsia—Rosuvastatin—atherosclerosis	3.11e-05	0.000685	CcSEcCtD
Lovastatin—Flatulence—Niacin—atherosclerosis	3.1e-05	0.000684	CcSEcCtD
Lovastatin—Malaise—Simvastatin—atherosclerosis	3.09e-05	0.000682	CcSEcCtD
Lovastatin—Vertigo—Simvastatin—atherosclerosis	3.08e-05	0.000679	CcSEcCtD
Lovastatin—Leukopenia—Simvastatin—atherosclerosis	3.07e-05	0.000676	CcSEcCtD
Lovastatin—Myalgia—Ezetimibe—atherosclerosis	3.06e-05	0.000675	CcSEcCtD
Lovastatin—Chest pain—Ezetimibe—atherosclerosis	3.06e-05	0.000675	CcSEcCtD
Lovastatin—Arthralgia—Ezetimibe—atherosclerosis	3.06e-05	0.000675	CcSEcCtD
Lovastatin—Flatulence—Pravastatin—atherosclerosis	3.06e-05	0.000673	CcSEcCtD
Lovastatin—Dysgeusia—Pravastatin—atherosclerosis	3.04e-05	0.000669	CcSEcCtD
Lovastatin—Muscle spasms—Niacin—atherosclerosis	3.03e-05	0.000667	CcSEcCtD
Lovastatin—Discomfort—Ezetimibe—atherosclerosis	3.03e-05	0.000667	CcSEcCtD
Lovastatin—Constipation—Rosuvastatin—atherosclerosis	3.02e-05	0.000665	CcSEcCtD
Lovastatin—Pain—Rosuvastatin—atherosclerosis	3.02e-05	0.000665	CcSEcCtD
Lovastatin—Dry mouth—Ezetimibe—atherosclerosis	3e-05	0.00066	CcSEcCtD
Lovastatin—Muscle spasms—Pravastatin—atherosclerosis	2.98e-05	0.000657	CcSEcCtD
Lovastatin—Vision blurred—Niacin—atherosclerosis	2.97e-05	0.000654	CcSEcCtD
Lovastatin—Confusional state—Ezetimibe—atherosclerosis	2.96e-05	0.000652	CcSEcCtD
Lovastatin—Anaphylactic shock—Ezetimibe—atherosclerosis	2.94e-05	0.000647	CcSEcCtD
Lovastatin—Vision blurred—Pravastatin—atherosclerosis	2.92e-05	0.000644	CcSEcCtD
Lovastatin—Arthralgia—Simvastatin—atherosclerosis	2.92e-05	0.000643	CcSEcCtD
Lovastatin—Chest pain—Simvastatin—atherosclerosis	2.92e-05	0.000643	CcSEcCtD
Lovastatin—Myalgia—Simvastatin—atherosclerosis	2.92e-05	0.000643	CcSEcCtD
Lovastatin—Infection—Ezetimibe—atherosclerosis	2.92e-05	0.000643	CcSEcCtD
Lovastatin—Feeling abnormal—Rosuvastatin—atherosclerosis	2.91e-05	0.000641	CcSEcCtD
Lovastatin—Anxiety—Simvastatin—atherosclerosis	2.91e-05	0.000641	CcSEcCtD
Lovastatin—Tremor—Pravastatin—atherosclerosis	2.91e-05	0.00064	CcSEcCtD
Lovastatin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	2.89e-05	0.000636	CcSEcCtD
Lovastatin—Discomfort—Simvastatin—atherosclerosis	2.89e-05	0.000636	CcSEcCtD
Lovastatin—Angioedema—Niacin—atherosclerosis	2.88e-05	0.000634	CcSEcCtD
Lovastatin—Ill-defined disorder—Pravastatin—atherosclerosis	2.88e-05	0.000634	CcSEcCtD
Lovastatin—Thrombocytopenia—Ezetimibe—atherosclerosis	2.87e-05	0.000633	CcSEcCtD
Lovastatin—Angioedema—Pravastatin—atherosclerosis	2.83e-05	0.000624	CcSEcCtD
Lovastatin—Vertigo—Niacin—atherosclerosis	2.83e-05	0.000623	CcSEcCtD
Lovastatin—Confusional state—Simvastatin—atherosclerosis	2.82e-05	0.000622	CcSEcCtD
Lovastatin—Leukopenia—Niacin—atherosclerosis	2.82e-05	0.000621	CcSEcCtD
Lovastatin—ABCB1—cardiovascular system—atherosclerosis	2.81e-05	0.00581	CbGeAlD
Lovastatin—Urticaria—Rosuvastatin—atherosclerosis	2.81e-05	0.000618	CcSEcCtD
Lovastatin—Anaphylactic shock—Simvastatin—atherosclerosis	2.8e-05	0.000617	CcSEcCtD
Lovastatin—Malaise—Pravastatin—atherosclerosis	2.8e-05	0.000616	CcSEcCtD
Lovastatin—Abdominal pain—Rosuvastatin—atherosclerosis	2.79e-05	0.000615	CcSEcCtD
Lovastatin—Vertigo—Pravastatin—atherosclerosis	2.79e-05	0.000614	CcSEcCtD
Lovastatin—Infection—Simvastatin—atherosclerosis	2.78e-05	0.000613	CcSEcCtD
Lovastatin—Leukopenia—Pravastatin—atherosclerosis	2.78e-05	0.000612	CcSEcCtD
Lovastatin—Thrombocytopenia—Simvastatin—atherosclerosis	2.74e-05	0.000604	CcSEcCtD
Lovastatin—Myalgia—Niacin—atherosclerosis	2.68e-05	0.000591	CcSEcCtD
Lovastatin—Arthralgia—Niacin—atherosclerosis	2.68e-05	0.000591	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	2.68e-05	0.000589	CcSEcCtD
Lovastatin—Anorexia—Simvastatin—atherosclerosis	2.67e-05	0.000588	CcSEcCtD
Lovastatin—Insomnia—Ezetimibe—atherosclerosis	2.66e-05	0.000585	CcSEcCtD
Lovastatin—Arthralgia—Pravastatin—atherosclerosis	2.64e-05	0.000582	CcSEcCtD
Lovastatin—Myalgia—Pravastatin—atherosclerosis	2.64e-05	0.000582	CcSEcCtD
Lovastatin—Chest pain—Pravastatin—atherosclerosis	2.64e-05	0.000582	CcSEcCtD
Lovastatin—Paraesthesia—Ezetimibe—atherosclerosis	2.64e-05	0.000581	CcSEcCtD
Lovastatin—Anxiety—Pravastatin—atherosclerosis	2.63e-05	0.00058	CcSEcCtD
Lovastatin—Dry mouth—Niacin—atherosclerosis	2.62e-05	0.000578	CcSEcCtD
Lovastatin—Dyspnoea—Ezetimibe—atherosclerosis	2.62e-05	0.000577	CcSEcCtD
Lovastatin—Discomfort—Pravastatin—atherosclerosis	2.61e-05	0.000575	CcSEcCtD
Lovastatin—Hypersensitivity—Rosuvastatin—atherosclerosis	2.6e-05	0.000573	CcSEcCtD
Lovastatin—Dyspepsia—Ezetimibe—atherosclerosis	2.58e-05	0.000569	CcSEcCtD
Lovastatin—Anaphylactic shock—Niacin—atherosclerosis	2.57e-05	0.000566	CcSEcCtD
Lovastatin—Confusional state—Pravastatin—atherosclerosis	2.55e-05	0.000562	CcSEcCtD
Lovastatin—Decreased appetite—Ezetimibe—atherosclerosis	2.55e-05	0.000562	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	2.55e-05	0.000562	CcSEcCtD
Lovastatin—Asthenia—Rosuvastatin—atherosclerosis	2.53e-05	0.000558	CcSEcCtD
Lovastatin—Insomnia—Simvastatin—atherosclerosis	2.53e-05	0.000558	CcSEcCtD
Lovastatin—Anaphylactic shock—Pravastatin—atherosclerosis	2.53e-05	0.000558	CcSEcCtD
Lovastatin—Fatigue—Ezetimibe—atherosclerosis	2.53e-05	0.000558	CcSEcCtD
Lovastatin—Infection—Pravastatin—atherosclerosis	2.51e-05	0.000554	CcSEcCtD
Lovastatin—Paraesthesia—Simvastatin—atherosclerosis	2.51e-05	0.000554	CcSEcCtD
Lovastatin—Pain—Ezetimibe—atherosclerosis	2.51e-05	0.000553	CcSEcCtD
Lovastatin—Constipation—Ezetimibe—atherosclerosis	2.51e-05	0.000553	CcSEcCtD
Lovastatin—Pruritus—Rosuvastatin—atherosclerosis	2.5e-05	0.00055	CcSEcCtD
Lovastatin—Dyspnoea—Simvastatin—atherosclerosis	2.5e-05	0.00055	CcSEcCtD
Lovastatin—Thrombocytopenia—Pravastatin—atherosclerosis	2.48e-05	0.000546	CcSEcCtD
Lovastatin—ABCB1—adipose tissue—atherosclerosis	2.48e-05	0.00513	CbGeAlD
Lovastatin—Dyspepsia—Simvastatin—atherosclerosis	2.46e-05	0.000543	CcSEcCtD
Lovastatin—CYP3A4—liver—atherosclerosis	2.45e-05	0.00508	CbGeAlD
Lovastatin—Anorexia—Niacin—atherosclerosis	2.45e-05	0.00054	CcSEcCtD
Lovastatin—Decreased appetite—Simvastatin—atherosclerosis	2.43e-05	0.000536	CcSEcCtD
Lovastatin—Feeling abnormal—Ezetimibe—atherosclerosis	2.42e-05	0.000533	CcSEcCtD
Lovastatin—Diarrhoea—Rosuvastatin—atherosclerosis	2.42e-05	0.000532	CcSEcCtD
Lovastatin—Fatigue—Simvastatin—atherosclerosis	2.41e-05	0.000532	CcSEcCtD
Lovastatin—CYP2D6—liver—atherosclerosis	2.41e-05	0.005	CbGeAlD
Lovastatin—Anorexia—Pravastatin—atherosclerosis	2.41e-05	0.000532	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ezetimibe—atherosclerosis	2.4e-05	0.000529	CcSEcCtD
Lovastatin—Pain—Simvastatin—atherosclerosis	2.39e-05	0.000527	CcSEcCtD
Lovastatin—Constipation—Simvastatin—atherosclerosis	2.39e-05	0.000527	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Niacin—atherosclerosis	2.34e-05	0.000516	CcSEcCtD
Lovastatin—Dizziness—Rosuvastatin—atherosclerosis	2.34e-05	0.000515	CcSEcCtD
Lovastatin—Urticaria—Ezetimibe—atherosclerosis	2.33e-05	0.000514	CcSEcCtD
Lovastatin—Insomnia—Niacin—atherosclerosis	2.33e-05	0.000512	CcSEcCtD
Lovastatin—Body temperature increased—Ezetimibe—atherosclerosis	2.32e-05	0.000511	CcSEcCtD
Lovastatin—Abdominal pain—Ezetimibe—atherosclerosis	2.32e-05	0.000511	CcSEcCtD
Lovastatin—Paraesthesia—Niacin—atherosclerosis	2.31e-05	0.000509	CcSEcCtD
Lovastatin—Feeling abnormal—Simvastatin—atherosclerosis	2.31e-05	0.000508	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	2.31e-05	0.000508	CcSEcCtD
Lovastatin—Dyspnoea—Niacin—atherosclerosis	2.29e-05	0.000505	CcSEcCtD
Lovastatin—Gastrointestinal pain—Simvastatin—atherosclerosis	2.29e-05	0.000504	CcSEcCtD
Lovastatin—Insomnia—Pravastatin—atherosclerosis	2.29e-05	0.000504	CcSEcCtD
Lovastatin—Paraesthesia—Pravastatin—atherosclerosis	2.27e-05	0.000501	CcSEcCtD
Lovastatin—Dyspepsia—Niacin—atherosclerosis	2.26e-05	0.000499	CcSEcCtD
Lovastatin—Dyspnoea—Pravastatin—atherosclerosis	2.26e-05	0.000497	CcSEcCtD
Lovastatin—Decreased appetite—Niacin—atherosclerosis	2.24e-05	0.000492	CcSEcCtD
Lovastatin—Dyspepsia—Pravastatin—atherosclerosis	2.23e-05	0.000491	CcSEcCtD
Lovastatin—Rash—Rosuvastatin—atherosclerosis	2.23e-05	0.000491	CcSEcCtD
Lovastatin—Dermatitis—Rosuvastatin—atherosclerosis	2.23e-05	0.00049	CcSEcCtD
Lovastatin—Urticaria—Simvastatin—atherosclerosis	2.22e-05	0.00049	CcSEcCtD
Lovastatin—Abdominal pain—Simvastatin—atherosclerosis	2.21e-05	0.000488	CcSEcCtD
Lovastatin—Body temperature increased—Simvastatin—atherosclerosis	2.21e-05	0.000488	CcSEcCtD
Lovastatin—Headache—Rosuvastatin—atherosclerosis	2.21e-05	0.000487	CcSEcCtD
Lovastatin—Decreased appetite—Pravastatin—atherosclerosis	2.2e-05	0.000485	CcSEcCtD
Lovastatin—Pain—Niacin—atherosclerosis	2.2e-05	0.000484	CcSEcCtD
Lovastatin—Fatigue—Pravastatin—atherosclerosis	2.18e-05	0.000481	CcSEcCtD
Lovastatin—Pain—Pravastatin—atherosclerosis	2.16e-05	0.000477	CcSEcCtD
Lovastatin—Constipation—Pravastatin—atherosclerosis	2.16e-05	0.000477	CcSEcCtD
Lovastatin—Hypersensitivity—Ezetimibe—atherosclerosis	2.16e-05	0.000477	CcSEcCtD
Lovastatin—Asthenia—Ezetimibe—atherosclerosis	2.11e-05	0.000464	CcSEcCtD
Lovastatin—Gastrointestinal pain—Niacin—atherosclerosis	2.1e-05	0.000463	CcSEcCtD
Lovastatin—Nausea—Rosuvastatin—atherosclerosis	2.1e-05	0.000462	CcSEcCtD
Lovastatin—Feeling abnormal—Pravastatin—atherosclerosis	2.09e-05	0.00046	CcSEcCtD
Lovastatin—Pruritus—Ezetimibe—atherosclerosis	2.08e-05	0.000458	CcSEcCtD
Lovastatin—Gastrointestinal pain—Pravastatin—atherosclerosis	2.07e-05	0.000456	CcSEcCtD
Lovastatin—Hypersensitivity—Simvastatin—atherosclerosis	2.06e-05	0.000454	CcSEcCtD
Lovastatin—Urticaria—Niacin—atherosclerosis	2.04e-05	0.00045	CcSEcCtD
Lovastatin—Abdominal pain—Niacin—atherosclerosis	2.03e-05	0.000448	CcSEcCtD
Lovastatin—Body temperature increased—Niacin—atherosclerosis	2.03e-05	0.000448	CcSEcCtD
Lovastatin—Urticaria—Pravastatin—atherosclerosis	2.01e-05	0.000443	CcSEcCtD
Lovastatin—Asthenia—Simvastatin—atherosclerosis	2.01e-05	0.000443	CcSEcCtD
Lovastatin—Diarrhoea—Ezetimibe—atherosclerosis	2.01e-05	0.000443	CcSEcCtD
Lovastatin—Body temperature increased—Pravastatin—atherosclerosis	2e-05	0.000441	CcSEcCtD
Lovastatin—Abdominal pain—Pravastatin—atherosclerosis	2e-05	0.000441	CcSEcCtD
Lovastatin—Pruritus—Simvastatin—atherosclerosis	1.98e-05	0.000436	CcSEcCtD
Lovastatin—Dizziness—Ezetimibe—atherosclerosis	1.94e-05	0.000428	CcSEcCtD
Lovastatin—Diarrhoea—Simvastatin—atherosclerosis	1.92e-05	0.000422	CcSEcCtD
Lovastatin—Hypersensitivity—Niacin—atherosclerosis	1.89e-05	0.000417	CcSEcCtD
Lovastatin—Vomiting—Ezetimibe—atherosclerosis	1.87e-05	0.000411	CcSEcCtD
Lovastatin—Hypersensitivity—Pravastatin—atherosclerosis	1.87e-05	0.000411	CcSEcCtD
Lovastatin—Dizziness—Simvastatin—atherosclerosis	1.85e-05	0.000408	CcSEcCtD
Lovastatin—Rash—Ezetimibe—atherosclerosis	1.85e-05	0.000408	CcSEcCtD
Lovastatin—Dermatitis—Ezetimibe—atherosclerosis	1.85e-05	0.000407	CcSEcCtD
Lovastatin—Asthenia—Niacin—atherosclerosis	1.84e-05	0.000406	CcSEcCtD
Lovastatin—Headache—Ezetimibe—atherosclerosis	1.84e-05	0.000405	CcSEcCtD
Lovastatin—Pruritus—Niacin—atherosclerosis	1.82e-05	0.000401	CcSEcCtD
Lovastatin—Asthenia—Pravastatin—atherosclerosis	1.82e-05	0.0004	CcSEcCtD
Lovastatin—Pruritus—Pravastatin—atherosclerosis	1.79e-05	0.000395	CcSEcCtD
Lovastatin—Vomiting—Simvastatin—atherosclerosis	1.78e-05	0.000392	CcSEcCtD
Lovastatin—Rash—Simvastatin—atherosclerosis	1.77e-05	0.000389	CcSEcCtD
Lovastatin—Dermatitis—Simvastatin—atherosclerosis	1.76e-05	0.000389	CcSEcCtD
Lovastatin—Diarrhoea—Niacin—atherosclerosis	1.76e-05	0.000387	CcSEcCtD
Lovastatin—Headache—Simvastatin—atherosclerosis	1.75e-05	0.000386	CcSEcCtD
Lovastatin—Nausea—Ezetimibe—atherosclerosis	1.74e-05	0.000384	CcSEcCtD
Lovastatin—ABCB1—liver—atherosclerosis	1.74e-05	0.0036	CbGeAlD
Lovastatin—Diarrhoea—Pravastatin—atherosclerosis	1.73e-05	0.000382	CcSEcCtD
Lovastatin—Dizziness—Niacin—atherosclerosis	1.7e-05	0.000375	CcSEcCtD
Lovastatin—Dizziness—Pravastatin—atherosclerosis	1.67e-05	0.000369	CcSEcCtD
Lovastatin—Nausea—Simvastatin—atherosclerosis	1.66e-05	0.000366	CcSEcCtD
Lovastatin—Vomiting—Niacin—atherosclerosis	1.63e-05	0.00036	CcSEcCtD
Lovastatin—Rash—Niacin—atherosclerosis	1.62e-05	0.000357	CcSEcCtD
Lovastatin—Dermatitis—Niacin—atherosclerosis	1.62e-05	0.000357	CcSEcCtD
Lovastatin—Headache—Niacin—atherosclerosis	1.61e-05	0.000355	CcSEcCtD
Lovastatin—Vomiting—Pravastatin—atherosclerosis	1.61e-05	0.000355	CcSEcCtD
Lovastatin—Rash—Pravastatin—atherosclerosis	1.6e-05	0.000352	CcSEcCtD
Lovastatin—Dermatitis—Pravastatin—atherosclerosis	1.59e-05	0.000351	CcSEcCtD
Lovastatin—Headache—Pravastatin—atherosclerosis	1.59e-05	0.000349	CcSEcCtD
Lovastatin—Nausea—Niacin—atherosclerosis	1.53e-05	0.000336	CcSEcCtD
Lovastatin—Nausea—Pravastatin—atherosclerosis	1.5e-05	0.000331	CcSEcCtD
Lovastatin—SLCO1B1—Metabolism—CAV1—atherosclerosis	9.02e-07	3.82e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—LDLR—atherosclerosis	9.01e-07	3.82e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOA1—atherosclerosis	9e-07	3.81e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—atherosclerosis	8.99e-07	3.81e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MTHFR—atherosclerosis	8.97e-07	3.8e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CG—atherosclerosis	8.96e-07	3.8e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NAMPT—atherosclerosis	8.96e-07	3.8e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMGCR—atherosclerosis	8.92e-07	3.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LIPC—atherosclerosis	8.91e-07	3.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOC3—atherosclerosis	8.85e-07	3.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOS3—atherosclerosis	8.83e-07	3.74e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CETP—atherosclerosis	8.8e-07	3.73e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARA—atherosclerosis	8.8e-07	3.73e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LDLR—atherosclerosis	8.8e-07	3.73e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARG—atherosclerosis	8.65e-07	3.67e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.62e-07	3.66e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK3—atherosclerosis	8.59e-07	3.64e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CETP—atherosclerosis	8.59e-07	3.64e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LCAT—atherosclerosis	8.57e-07	3.63e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FABP4—atherosclerosis	8.57e-07	3.63e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AGT—atherosclerosis	8.52e-07	3.61e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—INS—atherosclerosis	8.48e-07	3.6e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NAMPT—atherosclerosis	8.45e-07	3.58e-05	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.44e-07	3.58e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SCARB1—atherosclerosis	8.43e-07	3.57e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA4—atherosclerosis	8.41e-07	3.57e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LIPC—atherosclerosis	8.39e-07	3.56e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—atherosclerosis	8.37e-07	3.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NAMPT—atherosclerosis	8.37e-07	3.55e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOE—atherosclerosis	8.35e-07	3.54e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOC3—atherosclerosis	8.34e-07	3.54e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—atherosclerosis	8.34e-07	3.54e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—atherosclerosis	8.33e-07	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.32e-07	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LIPC—atherosclerosis	8.32e-07	3.53e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LDLR—atherosclerosis	8.29e-07	3.52e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAV1—atherosclerosis	8.27e-07	3.51e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOC3—atherosclerosis	8.27e-07	3.51e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP7A1—atherosclerosis	8.26e-07	3.5e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOA1—atherosclerosis	8.26e-07	3.5e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SCARB1—atherosclerosis	8.23e-07	3.49e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LDLR—atherosclerosis	8.22e-07	3.48e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	8.21e-07	3.48e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.21e-07	3.48e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CETP—atherosclerosis	8.1e-07	3.43e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.05e-07	3.41e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CETP—atherosclerosis	8.03e-07	3.4e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NOS3—atherosclerosis	7.97e-07	3.38e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.96e-07	3.38e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCA1—atherosclerosis	7.95e-07	3.37e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARG—atherosclerosis	7.93e-07	3.36e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HMOX1—atherosclerosis	7.87e-07	3.34e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—atherosclerosis	7.83e-07	3.32e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—atherosclerosis	7.78e-07	3.3e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—INS—atherosclerosis	7.77e-07	3.3e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMGCR—atherosclerosis	7.77e-07	3.3e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.75e-07	3.29e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.69e-07	3.26e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.64e-07	3.24e-05	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.62e-07	3.23e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOB—atherosclerosis	7.54e-07	3.2e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CG—atherosclerosis	7.54e-07	3.2e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.48e-07	3.17e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NOS3—atherosclerosis	7.44e-07	3.15e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTM1—atherosclerosis	7.34e-07	3.11e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMGCR—atherosclerosis	7.32e-07	3.11e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—atherosclerosis	7.29e-07	3.09e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—atherosclerosis	7.27e-07	3.08e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMGCR—atherosclerosis	7.26e-07	3.08e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALOX15—atherosclerosis	7.24e-07	3.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	7.24e-07	3.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA2—atherosclerosis	7.24e-07	3.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	7.24e-07	3.07e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—LPL—atherosclerosis	7.2e-07	3.05e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.18e-07	3.05e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCG5—atherosclerosis	7.15e-07	3.03e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—INS—atherosclerosis	7.13e-07	3.03e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—atherosclerosis	7.13e-07	3.02e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCA1—atherosclerosis	7.1e-07	3.01e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—atherosclerosis	7.08e-07	3e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX1—atherosclerosis	7.03e-07	2.98e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NFKB1—atherosclerosis	7.01e-07	2.97e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ABCA1—atherosclerosis	6.93e-07	2.94e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LPA—atherosclerosis	6.91e-07	2.93e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK8—atherosclerosis	6.89e-07	2.92e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CD36—atherosclerosis	6.84e-07	2.9e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.82e-07	2.89e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—atherosclerosis	6.82e-07	2.89e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—atherosclerosis	6.8e-07	2.89e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—BGN—atherosclerosis	6.69e-07	2.84e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA5—atherosclerosis	6.62e-07	2.81e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.55e-07	2.78e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—atherosclerosis	6.54e-07	2.77e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOB—atherosclerosis	6.53e-07	2.77e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.53e-07	2.77e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MTHFR—atherosclerosis	6.48e-07	2.75e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCA1—atherosclerosis	6.47e-07	2.74e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	6.37e-07	2.7e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARA—atherosclerosis	6.36e-07	2.7e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—atherosclerosis	6.36e-07	2.7e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—atherosclerosis	6.36e-07	2.69e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—atherosclerosis	6.3e-07	2.67e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—atherosclerosis	6.28e-07	2.66e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—atherosclerosis	6.26e-07	2.65e-05	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—atherosclerosis	6.24e-07	2.65e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—LPL—atherosclerosis	6.24e-07	2.65e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—atherosclerosis	6.24e-07	2.64e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AGT—atherosclerosis	6.16e-07	2.61e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALOX5—atherosclerosis	6.16e-07	2.61e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMOX1—atherosclerosis	6.09e-07	2.58e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—atherosclerosis	6.09e-07	2.58e-05	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—atherosclerosis	6.07e-07	2.57e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—atherosclerosis	6.04e-07	2.56e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—atherosclerosis	6.02e-07	2.55e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAV1—atherosclerosis	5.98e-07	2.54e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOA1—atherosclerosis	5.97e-07	2.53e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMOX1—atherosclerosis	5.94e-07	2.52e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CD36—atherosclerosis	5.93e-07	2.51e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—atherosclerosis	5.84e-07	2.48e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOB—atherosclerosis	5.83e-07	2.47e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—atherosclerosis	5.8e-07	2.46e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.72e-07	2.43e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOB—atherosclerosis	5.69e-07	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.67e-07	2.41e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.62e-07	2.38e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.6e-07	2.37e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—LPL—atherosclerosis	5.57e-07	2.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.55e-07	2.35e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—atherosclerosis	5.54e-07	2.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.52e-07	2.34e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARA—atherosclerosis	5.51e-07	2.34e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LIPC—atherosclerosis	5.49e-07	2.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOC3—atherosclerosis	5.45e-07	2.31e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.45e-07	2.31e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—LPL—atherosclerosis	5.43e-07	2.3e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—atherosclerosis	5.43e-07	2.3e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LDLR—atherosclerosis	5.42e-07	2.3e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOB—atherosclerosis	5.36e-07	2.27e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AGT—atherosclerosis	5.34e-07	2.26e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOB—atherosclerosis	5.32e-07	2.25e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—atherosclerosis	5.3e-07	2.25e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CETP—atherosclerosis	5.29e-07	2.24e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CD36—atherosclerosis	5.29e-07	2.24e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—atherosclerosis	5.26e-07	2.23e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—atherosclerosis	5.23e-07	2.22e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.22e-07	2.21e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAV1—atherosclerosis	5.18e-07	2.2e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—atherosclerosis	5.17e-07	2.19e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOA1—atherosclerosis	5.17e-07	2.19e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CD36—atherosclerosis	5.16e-07	2.19e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—INS—atherosclerosis	5.16e-07	2.19e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—LPL—atherosclerosis	5.12e-07	2.17e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—LPL—atherosclerosis	5.08e-07	2.15e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SCARB1—atherosclerosis	5.07e-07	2.15e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MTHFR—atherosclerosis	5.01e-07	2.13e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—atherosclerosis	5e-07	2.12e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—atherosclerosis	4.95e-07	2.1e-05	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—atherosclerosis	4.95e-07	2.1e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARA—atherosclerosis	4.92e-07	2.09e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MTHFR—atherosclerosis	4.89e-07	2.07e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CD36—atherosclerosis	4.87e-07	2.06e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CD36—atherosclerosis	4.82e-07	2.05e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARA—atherosclerosis	4.8e-07	2.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.79e-07	2.03e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AGT—atherosclerosis	4.76e-07	2.02e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—atherosclerosis	4.73e-07	2e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.72e-07	2e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—atherosclerosis	4.67e-07	1.98e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AGT—atherosclerosis	4.65e-07	1.97e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAV1—atherosclerosis	4.62e-07	1.96e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOA1—atherosclerosis	4.61e-07	1.96e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.61e-07	1.96e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.57e-07	1.94e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—atherosclerosis	4.56e-07	1.93e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—atherosclerosis	4.55e-07	1.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARA—atherosclerosis	4.52e-07	1.92e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—atherosclerosis	4.52e-07	1.92e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAV1—atherosclerosis	4.51e-07	1.91e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOA1—atherosclerosis	4.5e-07	1.91e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARA—atherosclerosis	4.48e-07	1.9e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—INS—atherosclerosis	4.47e-07	1.89e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—atherosclerosis	4.4e-07	1.87e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AGT—atherosclerosis	4.38e-07	1.86e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AGT—atherosclerosis	4.34e-07	1.84e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—atherosclerosis	4.29e-07	1.82e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCA1—atherosclerosis	4.27e-07	1.81e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—atherosclerosis	4.26e-07	1.8e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAV1—atherosclerosis	4.25e-07	1.8e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOA1—atherosclerosis	4.24e-07	1.8e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAV1—atherosclerosis	4.22e-07	1.79e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CG—atherosclerosis	4.21e-07	1.79e-05	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—atherosclerosis	4.21e-07	1.78e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOA1—atherosclerosis	4.21e-07	1.78e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—atherosclerosis	4.14e-07	1.75e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CG—atherosclerosis	4.11e-07	1.74e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—atherosclerosis	4.1e-07	1.74e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—atherosclerosis	4.07e-07	1.72e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—atherosclerosis	4.06e-07	1.72e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—INS—atherosclerosis	3.99e-07	1.69e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—atherosclerosis	3.97e-07	1.68e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—atherosclerosis	3.92e-07	1.66e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—INS—atherosclerosis	3.89e-07	1.65e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.87e-07	1.64e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.84e-07	1.63e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—atherosclerosis	3.74e-07	1.59e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—atherosclerosis	3.71e-07	1.57e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—INS—atherosclerosis	3.67e-07	1.56e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—atherosclerosis	3.66e-07	1.55e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.66e-07	1.55e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—atherosclerosis	3.66e-07	1.55e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—INS—atherosclerosis	3.64e-07	1.54e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.58e-07	1.52e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—atherosclerosis	3.57e-07	1.51e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOB—atherosclerosis	3.51e-07	1.49e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—atherosclerosis	3.5e-07	1.48e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—atherosclerosis	3.42e-07	1.45e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—atherosclerosis	3.41e-07	1.45e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.41e-07	1.45e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—atherosclerosis	3.36e-07	1.43e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—LPL—atherosclerosis	3.35e-07	1.42e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—atherosclerosis	3.33e-07	1.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—atherosclerosis	3.27e-07	1.39e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—atherosclerosis	3.22e-07	1.36e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—atherosclerosis	3.2e-07	1.36e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—atherosclerosis	3.19e-07	1.35e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CD36—atherosclerosis	3.18e-07	1.35e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—atherosclerosis	3.13e-07	1.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—atherosclerosis	3.12e-07	1.32e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.01e-07	1.28e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARA—atherosclerosis	2.96e-07	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.94e-07	1.25e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.92e-07	1.24e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—atherosclerosis	2.88e-07	1.22e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AGT—atherosclerosis	2.86e-07	1.21e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—atherosclerosis	2.81e-07	1.19e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAV1—atherosclerosis	2.78e-07	1.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOA1—atherosclerosis	2.77e-07	1.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.53e-07	1.07e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—atherosclerosis	2.44e-07	1.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—INS—atherosclerosis	2.4e-07	1.02e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—atherosclerosis	2.2e-07	9.32e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—atherosclerosis	2.1e-07	8.92e-06	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—atherosclerosis	2.08e-07	8.82e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.92e-07	8.15e-06	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—atherosclerosis	1.8e-07	7.64e-06	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—atherosclerosis	1.61e-07	6.82e-06	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—atherosclerosis	1.57e-07	6.65e-06	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—atherosclerosis	1.48e-07	6.27e-06	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—atherosclerosis	1.47e-07	6.21e-06	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—atherosclerosis	9.67e-08	4.1e-06	CbGpPWpGaD
